2 ms·
Thousands of british AstraSeneca/Oxford trials received half the dosis, and what happened? 99% effectiveness. Much better than with the full dosis. But in the s
by rurban 6y ago
Thousands of british AstraSeneca/Oxford trials received half the dosis, and what happened? 99% effectiveness. Much better than with the full dosis. But in the sample was noone over 65.
That was the whole problem with the late AstraSeneca approval process. Some Italian manufacturer used a different diluter which lead to the famous mistake.
Apparently this news producer never heard of it. Apparently they don't do their own research. Eg https://www.bbc.com/news/health-55086927 https://www.bbc.com/news/health-55086927